Breathe BioMedical Inc. (BRTH)

Breathe BioMedical will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Breathe BioMedical Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Selling, General & Admin	4.43	2.7	2.52
Research & Development	2.09	1.82	1.6
Other Operating Expenses	2.65	0.88	0.93
Operating Expenses	9.17	5.4	5.05
Operating Income	-9.17	-5.4	-5.05
Interest Expense / Income	0.02	-0.01	-0.01
Other Expense / Income	-0.83	-0.93	-1.07
Pretax Income	-8.36	-4.46	-3.97
Net Income	-8.36	-4.46	-3.97
Free Cash Flow	-5.22	-3.53	-3.5
EBITDA	-7.88	-4.21	-
Depreciation & Amortization	0.47	0.26	0.22
EBIT	-8.35	-4.47	-

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).